ArticleEuropean heart journal. Case reports2026
Isolated granulomatous pulmonary artery vasculitis associated with Hughes-Stovin syndrome: a case report.
Article in European heart journal. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hughes-Stovin syndrome (HSS) is an exceptionally rare vasculitis, characterized by pulmonary artery aneurysms with Case summary: We describe a 71-year-old male who presented with progressive dyspnoea and chest pain. Serial imaging demonstrated rapid enlargement of a main pulmonary artery aneurysm from 5 mm to 68 × 55 mm over 18 months, prompting surgical repair. Histopathological examination of the resected pulmonary artery demonstrated granulomatous arteritis with multinucleated giant cells, transmural inflammation, and disruption of the elastic lamina, confirming isolated pulmonary artery vasculitis. In the context of pulmonary artery aneurysm, normal coagulation studies and systemic exclusion of alternative causes including Behcet disease, giant cell arteritis, Takayasu arteritis, infection, and malignancy, the findings were considered most consistent with HSS. Following multidisciplinary review, immunosuppression was commenced with corticosteroid and methotrexate before transition to tocilizumab and mycophenolate mofetil. Recurrent pulmonary thrombosis despite therapeutic apixaban required conversion to therapeutic enoxaparin. At latest follow-up, the patient remained clinically stable with no evidence of active vasculitis or recurrent aneurysm. Conclusion: This case highlights a rare presentation of isolated granulomatous pulmonary artery vasculitis associated with HSS in an older patient. The case demonstrates the importance of cautious diagnostic classification and exclusion of alternative diagnoses through serial multimodal imaging, timely surgical intervention, prompt commencement of immunosuppression, and multidisciplinary care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.